These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32634286)

  • 21. Clinical Trials of Aspirin Treatment After Desensitization in Aspirin-Exacerbated Respiratory Disease.
    Kowalski ML; Wardzyńska A; Makowska JS
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):705-717. PubMed ID: 27712765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dupilumab as an adjunct to surgery in patients with aspirin-exacerbated respiratory disease.
    Patel P; Bensko JC; Bhattacharyya N; Laidlaw TM; Buchheit KM
    Ann Allergy Asthma Immunol; 2022 Mar; 128(3):326-328. PubMed ID: 34863953
    [No Abstract]   [Full Text] [Related]  

  • 23. Aspirin desensitization for aspirin-exacerbated respiratory disease in the era of biologics: Clinical perspective.
    Bosso JV
    Int Forum Allergy Rhinol; 2021 Apr; 11(4):822-823. PubMed ID: 33070455
    [No Abstract]   [Full Text] [Related]  

  • 24. Intranasal ketorolac-induced pancreatitis as a complication of modified oral aspirin desensitization in a patient with aspirin-exacerbated respiratory disease.
    Luskin KT; Bosso JV; Simon RA
    J Allergy Clin Immunol Pract; 2020 Mar; 8(3):1147-1148. PubMed ID: 31678291
    [No Abstract]   [Full Text] [Related]  

  • 25. Aspirin and salicylate in respiratory disease.
    Mitchell JE; Skypala I
    Rhinology; 2013 Sep; 51(3):195-205. PubMed ID: 23943725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aspirin-Exacerbated Respiratory Disease.
    White AA; Stevenson DD
    N Engl J Med; 2018 Sep; 379(11):1060-1070. PubMed ID: 30207919
    [No Abstract]   [Full Text] [Related]  

  • 27. Performing Aspirin Desensitization in Aspirin-Exacerbated Respiratory Disease.
    Waldram JD; Simon RA
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):693-703. PubMed ID: 27712764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endoscopic sinus surgery improves aspirin treatment response in aspirin-exacerbated respiratory disease patients.
    Shah SJ; Abuzeid WM; Ponduri A; Pelletier T; Ren Z; Keskin T; Roizen G; Rosenstreich D; Ferastraoaru D; Jerschow E
    Int Forum Allergy Rhinol; 2019 Dec; 9(12):1401-1408. PubMed ID: 31569308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rhinosinusitis and nasal polyps in aspirin-exacerbated respiratory disease.
    Mullol J; Picado C
    Immunol Allergy Clin North Am; 2013 May; 33(2):163-76. PubMed ID: 23639706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Type 2 biologics reduce cumulative steroid exposure in aspirin-exacerbated respiratory disease.
    Ghiasi Y; Wangberg H; Bagsic SRS; White A
    Ann Allergy Asthma Immunol; 2022 Nov; 129(5):642-643. PubMed ID: 35908738
    [No Abstract]   [Full Text] [Related]  

  • 31. Pediatric-onset aspirin-exacerbated respiratory disease: Clinical characteristics, prevalence, and response to dupilumab.
    Bensko JC; McGill A; Palumbo M; Cahill KN; Laidlaw TM
    J Allergy Clin Immunol Pract; 2022 Sep; 10(9):2466-2468. PubMed ID: 35643277
    [No Abstract]   [Full Text] [Related]  

  • 32. Dysbiosis in aspirin-exacerbated respiratory disease.
    Cook KA; Domissy A; Simon RA; White AA; Modena BD
    Int Forum Allergy Rhinol; 2021 Jul; 11(7):1116-1120. PubMed ID: 33438331
    [No Abstract]   [Full Text] [Related]  

  • 33. Aspirin-exacerbated respiratory disease: burden of disease.
    Chang JE; White A; Simon RA; Stevenson DD
    Allergy Asthma Proc; 2012; 33(2):117-21. PubMed ID: 22525387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meta-analysis Exploring Sinopulmonary Outcomes of Aspirin Desensitization in Aspirin-Exacerbated Respiratory Disease.
    Chaaban MR; Moffatt D; Wright AE; Cowthran JA; Hsu ES; Kuo YF
    Otolaryngol Head Neck Surg; 2021 Jan; 164(1):11-18. PubMed ID: 32571140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update on aspirin desensitization for chronic rhinosinusitis with polyps in aspirin-exacerbated respiratory disease (AERD).
    Simon RA; Dazy KM; Waldram JD
    Curr Allergy Asthma Rep; 2015 Mar; 15(3):508. PubMed ID: 25663486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leukotriene-Associated Rash in Aspirin-Exacerbated Respiratory Disease.
    Laidlaw TM; Gakpo DH; Bensko JC; Buchheit K
    J Allergy Clin Immunol Pract; 2020 Oct; 8(9):3170-3171. PubMed ID: 32739465
    [No Abstract]   [Full Text] [Related]  

  • 37. Aspirin-exacerbated respiratory disease: characteristics and management strategies.
    Simon RA; Dazy KM; Waldram JD
    Expert Rev Clin Immunol; 2015; 11(7):805-17. PubMed ID: 25936612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aspirin Desensitization in Aspirin-Exacerbated Respiratory Disease: Consideration of a New Oral Challenge Protocol.
    Stevenson DD; White AA
    J Allergy Clin Immunol Pract; 2015; 3(6):932-3. PubMed ID: 26553618
    [No Abstract]   [Full Text] [Related]  

  • 39. An update on the management of aspirin-exacerbated respiratory disease.
    Lee JH; Jung CG; Park HS
    Expert Rev Respir Med; 2018 Feb; 12(2):137-143. PubMed ID: 29249187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. If aspirin-exacerbated respiratory disease treatment is a jigsaw puzzle, where do the aspirin and biologic pieces go?
    White AA
    Ann Allergy Asthma Immunol; 2022 May; 128(5):484-485. PubMed ID: 35489798
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.